Flies are increasingly utilized in drug discovery and chemical probing in vivo, which are novel technologies complementary to genetic probing in fundamental biological studies. Excellent genetic conservation, small size, short generation time, and over one hundred years of genetics make Drosophila an attractive model for rapid assay readout and use of analytical amounts of compound, enabling the experimental iterations needed in early drug development at a fraction of time and costs. Here, we describe an effective drug-testing pipeline using adult flies that can be easily implemented to study several disease models and different genotypes to discover novel molecular insight, probes, quality lead compounds, and develop novel prototype drugs.
Keywords: Drosophila; criblage de composés; drug discovery; drug screens; découverte de médicaments; maladies orphelines; modèles animaux; orphan disease; pathway probing; polycystic kidney disease; polykystose rénale; sondage des sentiers; whole-animal models.